Atlas Trials

Determination of the Prevalence and Severity of Expiratory Flow Limitation in Chronic Obstructive Pulmonary Disease Patients

Clinical trial NCT03851510 · TERMINATED

Trial details

NCT number
NCT03851510
Sponsor
Philips Respironics
Status
TERMINATED
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary DiseaseNoninvasive Ventilation
Start date
2019-03-14
Primary completion
2023-11-15
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.